Wird geladen...
The Use of Gene Therapy for Ablation of Atrial Fibrillation
Atrial fibrillation is the most common clinically significant cardiac arrhythmia, increasing the risk of stroke, heart failure and morbidity and mortality. Current therapies, including rate control and rhythm control by antiarrhythmic drugs or ablation therapy, are moderately effective but far from...
Gespeichert in:
| Veröffentlicht in: | Arrhythm Electrophysiol Rev |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Radcliffe Cardiology
2014
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4711550/ https://ncbi.nlm.nih.gov/pubmed/26835081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/aer.2014.3.3.139 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|